Impact of sodium-glucose cotransporter-2 inhibitors on recurrence after atrial fibrillation ablation in patients with indications for SGLT2i therapy

10 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and myocardial substrate Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by